|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.23 USD | -4.17% |
|
-8.25% | -10.13% |
| May. 08 | Cassava Sciences Raises More Than $125 Million From Warrant Distribution | MT |
| May. 06 | North American Morning Briefing : Stock Futures -2- | DJ |
Pain Therapeutics Inc. announced the appointment of Michael Marsman, Pharm.D., as Senior Vice President, Regulatory Affairs. Dr. Marsman will be responsible for developing and implementing regulatory strategies to gain drug approvals. He previously led regulatory affairs at Pain Therapeutics for nearly a decade before leaving in 2012 amid a corporate reorganization.
Dr. Marsman most recently served as V.P. Regulatory Affairs at Impax Laboratories.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.13% | 875M | |
| +3.91% | 109B | |
| +10.87% | 105B | |
| +1.28% | 22.25B | |
| -13.14% | 22.09B | |
| -7.05% | 18.68B | |
| -38.36% | 17.58B | |
| -10.66% | 16.85B | |
| +3.75% | 13.76B | |
| +36.70% | 12.46B |
CASSAVA SCIENCES, INC. 